Health minister inaugurates new facilities at IGIMS
Tired of too many ads? go ad free now
The minister said the 12-bed paediatric oncology ward has been built to provide a family-like atmosphere to the children undergoing treatment there. The facilities include playing, studying with a child psychologist and dietician.
The minister, along with Digha MLA Sanjeev Chaurasia, also met children who have overcome cancer with great joy and inquired about their well-being.
Pandey said the modern modular OTs in the cancer department include high quality ventilation and filtration systems for infection control of the patients of the State Cancer Centre during and after surgery.
"The new OTs will prove to be more effective in the fight against cancer," he said.
The minister thanked the IOCL for providing funds under CSR for the modern equipment in the physiotherapy department. "It will help in the treatment of spinal pain, spondylitis, problems due to nerve compression etc. An attempt is being made to give a modern form to physiotherapy for many diseases like brain injury, Parkinson and stroke.
The equipment have been developed with indigenous technology by experts from institutions like AIIMS, New Delhi and IIT," he said.
The minister thanked the IGIMS director, Dr Binde Kumar, deputy director (administration) Dr Vibhuti Prasanna Sinha, all senior doctors, Dr Nilesh Mohan, Dr Jayant Prakash, Dr Rakesh Kumar Singh, Dr P K Dubey, Dr P K Jha, Dr Santosh Kumar, Dr Raj Kumar, Dr Nitesh Kumar, Dr Pradeep Jaiswal and Dr Pritpal Singh for their continuous service to the patients.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
39 minutes ago
- News18
MedGenome raises USD 47.5 mn in Series E funding round
New Delhi, Jul 21 (PTI) Genomic diagnostics and research services company MedGenome on Monday said it has raised USD 47.5 million (over Rs 409 crore) in Series E funding round from private equity firm Maj Invest and existing investor Novo Holdings. The round also saw participation from Sofina, an existing shareholder in the company, the Bengaluru-based firm said in a statement. The funding will enable the company to broaden access to its genomics and integrated diagnostics solutions across India and other emerging markets, it added. 'This fundraise also reflects the growing adoption of genomics in personalised and preventive healthcare in India as well as other emerging economies," MedGenome CEO Vedam Ramprasad said. MedGenome offers over 1,300 high-end genetic tests across major disease categories – oncology, inherited diseases, reproductive diseases, infectious diseases, and preventive wellness. PTI MSS MSS SHW Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
2 hours ago
- Time of India
ADIA to invest $200 million in Gujarat-based medtech co Meril
Ahmedabad: Abu Dhabi Investment Authority (ADIA) on Sunday announced it has signed definitive agreements to invest USD 200 million (approximately Rs 1,723 crore) in Gujarat-based medical devices manufacturer Meril, acquiring close to a 3% stake. The transaction values Meril at $6.6 billion (around Rs 56,859 crore). The deal awaits regulatory approval from the Competition Commission of India (CCI). The investment marks ADIA's latest play in India's expanding medical devices manufacturing space. Following the completion of the deal, Meril will be backed by two prominent global investors - ADIA and Warburg Pincus , which had earlier invested in the company. Founded by the Bilakhia Group, Meril is headquartered in Vapi, where it operates a 100-acre, vertically integrated MedTech campus powered entirely by green energy. The company develops and manufactures a range of clinically advanced products including cardiovascular devices, structural heart solutions, surgical robotics, orthopaedic implants, in-vitro diagnostics, and endo-surgery technologies. By far, Meril has invested Rs 1,400 crore in its Vapi facility. In Dec 2024, the company also inaugurated its new medical devices plant in Vapi. Meril exports its products to over 150 countries through a network of more than 35 subsidiaries. The company employs over 13,000 people globally and operates 12 international training academies, where it trains more than 10,000 healthcare professionals annually. tnn
Time of India
2 hours ago
- Time of India
Brigade Hotel Ventures IPO price band set at Rs 85–90. Check key details
Brigade Hotel Ventures, the hospitality subsidiary of Bengaluru-based real estate major Brigade Enterprises Ltd (BEL), has announced the launch of its initial public offering ( IPO ), setting a price band of Rs 85 to Rs 90 per share. The issue, totaling Rs 759.60 crore, is entirely a fresh offer with no Offer for Sale (OFS) component, ensuring that all proceeds will go directly towards funding the company's growth initiatives. Explore courses from Top Institutes in Select a Course Category Healthcare MBA Others MCA Data Science Management Cybersecurity CXO Public Policy Finance others Data Science Product Management Artificial Intelligence Leadership healthcare Data Analytics Technology Degree Digital Marketing Operations Management Design Thinking Project Management Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details At the upper end of the price band, the company will command a market valuation of over Rs 3,400 crore. The IPO will open for subscription on July 24 and close on July 28. Investors can bid for a minimum of 166 shares and in multiples thereafter. The allotment of shares is expected to be finalized on July 29, with the company aiming for a July 31 listing on both the BSE and NSE. The funds raised through the IPO will be strategically allocated. Approximately Rs 468.14 crore will be used to repay existing debt, while Rs 107.52 crore will go towards acquiring an undivided share of land from the promoter, BEL. The remaining proceeds will be used for acquisitions, other strategic initiatives, and general corporate purposes indicating a strong intent to deleverage and expand operations. Brigade Hotel Ventures began its journey in the hospitality sector in 2004 and opened its first hotel, Grand Mercure Bangalore, in 2009. The company now operates nine hotels across key urban centers including Bengaluru, Mysuru, Chennai, Kochi, and Gujarat's GIFT City, offering a total of 1,604 keys. Its properties are operated under prestigious international brands like Marriott, Accor, and InterContinental Hotels Group (IHG), adding credibility and operational strength to its growing portfolio. In terms of IPO allocation, 75% of the issue is reserved for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and the remaining 10% for retail investors. Earlier this month, Brigade Hotel Ventures raised Rs 126 crore in a pre-IPO round by issuing shares to 360 ONE Alternates Asset Management, highlighting early institutional interest. With strong backing from its parent company, partnerships with global hotel chains, and a clear roadmap for growth and financial strengthening, Brigade Hotel Ventures' IPO could attract significant attention from investors looking to tap into India's recovering hospitality sector. JM Financial and ICICI Securities are acting as the book-running lead managers for the issue. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
